Drug makers to face crackdown on rebates

It has long been a tough challenge for health authorities to break corrupt ties between drug makers, doctors and pharmacists.

Seemingly, however, the crackdown on illegal rebate activities in the drug industry has been on the decreasing trend over the recent months.

By contrast, the number of whistle blowers who reported a corruption case to the government is on the rise due to the planne...